2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer
Data(s) |
01/08/2015
|
---|---|
Resumo |
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11–12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease. |
Identificador | |
Publicador |
Oxford University Press |
Relação |
DOI:10.1093/annonc/mdv187 Eberhardt, W. E. E., De Ruysscher, D., Weder, W., Le Péchoux, C., De Leyn, P., Hoffmann, H., Westeel, V., Stahel, R., Felip, E., Peters, S., O'Byrne, Ken, & Panel Members, (2015) 2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer. Annals of Oncology, 26(8), pp. 1573-1588. |
Direitos |
Copyright 2015 The Authors |
Fonte |
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation |
Palavras-Chave | #non-small-cell lung cancer #locally advanced #stage III #recommendations #ESMO |
Tipo |
Journal Article |